New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more Philadelphia Becomes First USContinue Reading

TUESDAY, April 12, 2022 (HealthDay News) — If you suffer from headaches, you have plenty of company. Headaches afflict half of the world’s population, and women are more likely to get them than men, a new paper says. “We found that the prevalence of headache disorders remains high worldwide andContinue Reading

TUESDAY, April 12, 2022 (HealthDay News) — Quitting smoking can give heart disease patients nearly five additional years of life without heart problems, according to a new study. “Kicking the habit appears to be as effective as taking three medications for preventing heart attacks and strokes in those with aContinue Reading

Breakthrough CAR-T Therapy May Shrink Solid Tumors: An immune system-based treatment that has shown its mettle against blood cancers might prove useful in battling tumors, early trial data show. Read more Could COVID Infection After 50 Leave You Vulnerable to Shingles? Researchers found those 50 and older who were infectedContinue Reading